Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

Historical Holders from Q2 2021 to Q3 2025

Symbol
TPST on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
4,404,649
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
269,772
Holdings value
$2,773,256
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Versant Venture Capital VI, L.P. 3.7% -22% $1,108,210 -$13,298,570 162,972 -92.3% Versant Vantage II, L.P. 11 Aug 2025

Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 269,772 $2,773,256 $10.28 1
2025 Q2 269,772 $1,834,450 +$4,501 $6.80 1
2025 Q1 2,479,851 $1,829,980 -$3,627,304 $0.7380 21
2024 Q4 6,781,654 $5,658,643 +$2,859,460 $0.8345 34
2024 Q3 2,830,709 $3,944,228 +$794,367 $1.40 28
2024 Q2 2,147,122 $4,702,091 +$383,802 $2.19 23
2024 Q1 1,864,165 $7,287,955 -$1,467,022 $3.91 28
2023 Q4 2,213,399 $9,740,052 +$3,515,841 $4.40 32
2023 Q3 3,411,773 $1,049,205 -$338,780 $0.3051 24
2023 Q2 3,827,439 $4,860,526 +$899,836 $1.27 22
2023 Q1 3,109,553 $7,213,648 +$110,262 $2.32 16
2022 Q4 3,067,678 $3,536,532 -$23,290 $1.15 13
2022 Q3 3,081,085 $5,359,127 -$82,167 $1.74 14
2022 Q2 3,113,726 $6,672,000 +$2,166,223 $2.14 15
2022 Q1 2,100,798 $7,118,000 -$1,240,495 $3.38 13
2021 Q4 2,349,675 $12,407,000 -$1,465,918 $5.28 16
2021 Q3 2,190,280 $31,692,000 +$5,245,036 $14.47 18
2021 Q2 1,834,857 $20,524,000 +$20,521,000 $11.18 19